Vanguard Global Advisers’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$90.5K Buy
1,222
+14
+1% +$998 ﹤0.01% 2820
2026
Q2
$83.3K Hold
1,208
– – ﹤0.01% 2858
2026
Q1
$74.9K Buy
+1,208
New +$76.1K ﹤0.01% 2846

Other funds holding UTMD

Vanguard Global Advisers's UTMD Position: Q3 2026 in Review

Vanguard Global Advisers increased its Utah Medical Products (UTMD) stake by 1.2% in Q3 2026, buying an estimated $998 and bringing the position to 1,222 shares worth $90.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2820.

Vanguard Global Advisers first reported a position in UTMD in Q1 2026 and has held it in 3 quarters since. 128 funds tracked by Wall St. Rank hold UTMD as of Q3 2026.

  • Vanguard Global Advisers held 1,222 shares of Utah Medical Products worth $90.5K as of Q3 2026.
  • Vanguard Global Advisers bought 14 Utah Medical Products shares in Q3 2026, an estimated $998.
  • Utah Medical Products made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2820 holding.
  • Vanguard Global Advisers first reported a position in Utah Medical Products in Q1 2026 and has held it in 3 quarters since.
  • 128 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.